A long-term clinical study suggests that intervening before rheumatoid arthritis fully develops may significantly alter its trajectory. Treating people before rheumatoid arthritis (RA) fully develops may buy them something medicine rarely can: time. A new long-term study suggests that in people at high risk, early treatment with abatacept can push back the start of the […]
Full article can be found at: https://scitechdaily.com/breakthrough-drug-delays-rheumatoid-arthritis-for-years-after-treatment-ends/
